China
联系人 Olivia
Nanjing, Jiangsu
Edaravone is a novel free radical scavenger and was the first
neuroprotective agent that was clinically used for the treatment of
acute cerebral infarction. In May 2017, US FDA is approved
Edaravone for the treatment of amyotrophic lateral sclerosis (ALS).
Clinical studies showed that the treatment attenuated deterioration
of the disease when compared to placebo. It has been previously
investigated for the treatment of ischemic stroke, reperfusion
Injury, and myocardial Infarction as it possesses antioxidant and
anti-apoptotic properties. Being a low molecular weight molecule
with good water and lipid-soluble properties, it is therapeutically
advantageous in crossing the blood-brain barrier to mediate
nootropic and neuroprotective effects.
| 国家: | China |
| 型号: | - |
| 离岸价格: | 获取最新报价 |
| 位置: | China |
| 最小订单价格: | - |
| 最小订单: | 10 Kilogram |
| 包装细节: | 10kg/fabric drum, or customized |
| 交货时间: | 30 days |
| 供应能力: | 30000 Kilogram per Year |
| 付款方式: | T/T, L/C, D/P |
| 產品組 : | API |
